Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies.
The Biden administration recognises the difficulties in obtaining medical care and medicines for the American population, especially in the current economic climate and the increased cost of drugs.
“We know that prices are still too high for too many things, that times are still too tough for too many families,” Biden stated. “But we’ve made progress."
With the measures introduced with the Inflation Reduction Act and the price capping negotiations, efforts have been made by the US government to improve the situation for patients, and this latest ruling hopes to enable further access to medicine and medical supplies.
This measure, the Defence Production Act, should help to combat issues from disrupted supply chains and drug price increases. The administration includes this act in an announcement of 30 measures designed to increase access to medicine.
The act, backed by President Biden authorises the Department of Health and Human Services to use powers to enable investments in essential medicines. The White House also stated that areas of investment also include "medical countermeasures," encompassing supplies that diagnose, prevent, and treat diseases related to chemical, biological, radiological, or nuclear attacks or incidents.
There are also plans in place to improve the traceability and monitoring of pharmaceutical and industrial supply chains, to measure data, predict, and counter any disruptions that may occur, leading to problems further down the value chain that ultimately impacts patients. One such advancement from the Commerce Department is the development of novel tools and technology to assess potential risks to the supply chain, which they plan to use in conjunction with the Energy Department to monitor the renewable energy resource supply chain.
As the presidential campaigns are gearing up for the next election, polling surveys show that inflation and the economic climate are considered a high concern for the US population, and something for the candidates and parties to consider ahead of the election.
Supply chains have recovered markedly since the COVID-19 pandemic and from politically-driven disruptions, but there is still much work to be done to increase the security and reliability of supply chains and ensure that medical supplies can be accessed by the people in need.
Source: Reuters. Biden invokes Cold War-era measure to boost medical supplies. [Date Accessed 28/11/2023] www.reuters.com/world/us/biden-invoke-cold-war-era-law-boost-medical-supplies-2023-11-27/
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled. -
News Biden's $2 billion Biotech Boost
President Biden issues executive order to bolster U.S. biomanufacturing sector.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance